Financings Roundup
Cempra Inc., of Chapel Hill, N.C., said underwriters of its initial public offering exercised in full their option to purchase an additional 1.26 million shares of common stock at $6 per share, closing the overallotment on Feb. 27 and netting the company about $54.7 million from the offering. Cempra plans to use the proceeds to develop two of its product candidates, CEM-101 and Taksta.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.